| Income Statement |
| Operating Expenses | 1.59M |
|
| Research and Development Expense | 105.00 |
| Selling, General and Administrative Expense | 847.04K |
| Operating Income | -1.59M |
| Net Income | -985.41K |
| Net Income Common Stock | -985.41K |
| Net Income Common Stock (USD) | -693.70K |
| Consolidated Income | -985.41K |
| Earning Before Interest & Taxes (EBIT) | -985.41K |
| Earning Before Interest & Taxes (USD) | -693.70K |
| Weighted Average Shares | 185.02M |
| Weighted Average Shares Diluted | 185.02M |
| Balance Sheet |
| Cash and Equivalents | 38.57M |
| Cash and Equivalents (USD) | 27.15M |
| Trade and Non-Trade Receivables | 81.21K |
| Current Assets | 38.89M |
| Property, Plant & Equipment Net | 121.61M |
| Total Assets | 160.50M |
| Current Liabilities | 1.13M |
| Total Liabilities | 1.13M |
| Accumulated Retained Earnings (Deficit) | -82.59M |
| Accumulated Other Comprehensive Income | 7.13M |
| Shareholders Equity | 159.38M |
| Shareholders Equity (USD) | 112.20M |
| Assets Non-Current | 121.61M |
| Trade and Non-Trade Payables | 936.14K |
| Cash Flow |
| Depreciation, Amortization & Accretion | 38.95K |
| Net Cash Flow from Financing | 953.78K |
| Net Cash Flow / Change in Cash & Cash Equivalents | -1.30M |
| Capital Expenditure | -1.24M |
| Issuance (Purchase) of Equity Shares | 953.78K |
| Net Cash Flow from Investing | -1.24M |
| Net Cash Flow from Operations | -609.67K |
| Effect of Exchange Rate Changes on Cash | -406.66K |
| Share Based Compensation | 549.78K |